These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 17258825
1. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Giandalia ME, Palermo A, Mezzatesta G, Cerasola G. Int J Cardiol; 2007 Oct 18; 121(3):267-75. PubMed ID: 17258825 [Abstract] [Full Text] [Related]
2. Influence of metabolic syndrome on hypertension-related target organ damage. Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G. J Intern Med; 2005 Jun 18; 257(6):503-13. PubMed ID: 15910554 [Abstract] [Full Text] [Related]
3. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, Giandalia M, Geraci C, Buscemi S, Cerasola G. J Hum Hypertens; 2007 Nov 18; 21(11):854-60. PubMed ID: 17541385 [Abstract] [Full Text] [Related]
4. Central adiposity and left ventricular mass in obese children. Di Bonito P, Capaldo B, Forziato C, Sanguigno E, Di Fraia T, Scilla C, Cavuto L, Saitta F, Sibilio G, Moio N. Nutr Metab Cardiovasc Dis; 2008 Nov 18; 18(9):613-7. PubMed ID: 18083356 [Abstract] [Full Text] [Related]
5. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass. Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M. J Hypertens; 2007 Apr 18; 25(4):833-9. PubMed ID: 17351376 [Abstract] [Full Text] [Related]
6. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7). Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G. J Hypertens; 2009 Dec 18; 27(12):2465-71. PubMed ID: 19898252 [Abstract] [Full Text] [Related]
7. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy]. Kuch B, Muscholl M, Luchner A, Döring A, Riegger GA, Schunkert H, Hense HW. Z Kardiol; 1996 May 18; 85(5):334-42. PubMed ID: 8711946 [Abstract] [Full Text] [Related]
8. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. Norton GR, Majane OH, Libhaber E, Maseko MJ, Makaula S, Libhaber C, Woodiwiss AJ. J Hypertens; 2009 Sep 18; 27(9):1873-83. PubMed ID: 19512944 [Abstract] [Full Text] [Related]
9. Overweight, obesity and elevated blood pressure in children and adolescents. Schiel R, Beltschikow W, Kramer G, Stein G. Eur J Med Res; 2006 Mar 27; 11(3):97-101. PubMed ID: 16751109 [Abstract] [Full Text] [Related]
10. Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome. Mulè G, Nardi E, Cusimano P, Cottone S, Seddio G, Geraci C, Palermo A, Andronico G, Cerasola G. Am J Hypertens; 2008 Sep 27; 21(9):1055-61. PubMed ID: 18583983 [Abstract] [Full Text] [Related]
11. Effect of body mass index on left ventricular cavity size and ejection fraction. Dorbala S, Crugnale S, Yang D, Di Carli MF. Am J Cardiol; 2006 Mar 01; 97(5):725-9. PubMed ID: 16490446 [Abstract] [Full Text] [Related]
12. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K. Am J Hypertens; 2005 Jan 01; 18(1):23-9. PubMed ID: 15691613 [Abstract] [Full Text] [Related]
13. Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, Giandalia ME, Mezzatesta G, Andronico G, Cerasola G. Am J Hypertens; 2007 Feb 01; 20(2):197-203. PubMed ID: 17261467 [Abstract] [Full Text] [Related]
14. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients]. Kartal O, Inal V, Baysan O, Sağlam K. Anadolu Kardiyol Derg; 2008 Oct 01; 8(5):342-6. PubMed ID: 18849224 [Abstract] [Full Text] [Related]
15. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Mulè G, Cottone S, Mongiovì R, Cusimano P, Mezzatesta G, Seddio G, Volpe V, Nardi E, Andronico G, Piazza G, Cerasola G. Nutr Metab Cardiovasc Dis; 2006 Jan 01; 16(1):54-9. PubMed ID: 16399492 [Abstract] [Full Text] [Related]
16. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome. Sciarretta S, Ferrucci A, Ciavarella GM, De Paolis P, Venturelli V, Tocci G, De Biase L, Rubattu S, Volpe M. Am J Hypertens; 2007 Jul 01; 20(7):784-91. PubMed ID: 17586414 [Abstract] [Full Text] [Related]
17. Increased left ventricular mass in obese adolescents. Friberg P, Allansdotter-Johnsson A, Ambring A, Ahl R, Arheden H, Framme J, Johansson A, Holmgren D, Wåhlander H, Mårild S. Eur Heart J; 2004 Jun 01; 25(11):987-92. PubMed ID: 15172471 [Abstract] [Full Text] [Related]